Evolution of Drug Development and Regulatory Affairs: The Demonstrated Power of Artificial Intelligence.

Journal: Clinical therapeutics
Published Date: Jul 8, 2024

Abstract

PURPOSE: Artificial intelligence (AI) refers to technology capable of mimicking human cognitive functions and has important applications across all sectors and industries, including drug development. This has considerable implications for the regulation of drug development processes, as it is expected to transform both the way drugs are brought to market and the systems through which this process is controlled. There is currently insufficient evidence in published literature of the real-world applications of AI. Therefore, this narrative review investigated, collated, and elucidated the applications of AI in drug development and its regulatory processes.

Authors

  • Linda Nene
    Department of Pharmacology, School of Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
  • Brian Thabile Flepisi
    Department of Pharmacology, School of Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
  • Sarel Jacobus Brand
    Center of Excellence for Pharmaceutical Sciences, Department of Pharmacology, North-West University, Potchefstroom, South Africa.
  • Charlise Basson
    Department of Physiology, School of Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
  • Marissa Balmith
    Department of Pharmacology, School of Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa. Electronic address: marissa.balmith@up.ac.za.

Keywords

External Resources

Popular Topics
Recent Journals